par Fisher, Charles J.;Opal, S.M.;Dhainaut, Jean-Francois;Stephens, S;Zimmerman, J L;Nightingale, P;Harris, S J;Schein, R M;Panacek, E A;Vincent, Jean Louis
Référence Critical care medicine, 21, 3, page (318-327)
Publication Publié, 1993-03
Référence Critical care medicine, 21, 3, page (318-327)
Publication Publié, 1993-03
Article révisé par les pairs
Titre: |
|
Auteur: | Fisher, Charles J.; Opal, S.M.; Dhainaut, Jean-Francois; Stephens, S; Zimmerman, J L; Nightingale, P; Harris, S J; Schein, R M; Panacek, E A; Vincent, Jean Louis |
Informations sur la publication: | Critical care medicine, 21, 3, page (318-327) |
Statut de publication: | Publié, 1993-03 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Antibodies, Monoclonal -- therapeutic use |
Bacteria -- isolation & purification | |
Bacterial Physiological Phenomena | |
Cytokines -- blood | |
Female | |
Humans | |
Infection -- blood -- microbiology -- therapy | |
Interleukin-6 -- blood | |
Male | |
Middle Aged | |
Prospective Studies | |
Shock, Septic -- blood -- microbiology -- therapy | |
Tumor Necrosis Factor-alpha -- analysis -- biosynthesis -- immunology | |
Note générale: | Clinical Trial |
Clinical Trial, Phase II | |
Controlled Clinical Trial | |
Journal Article | |
Multicenter Study | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0090-3493 |
info:pmid/8440099 |